Correlation Between Exagen and Protagonist Therapeutics

Can any of the company-specific risk be diversified away by investing in both Exagen and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exagen Inc and Protagonist Therapeutics, you can compare the effects of market volatilities on Exagen and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Protagonist Therapeutics.

Diversification Opportunities for Exagen and Protagonist Therapeutics

-0.71

Correlation Coefficient

Exagen  Protagonist Therapeutics

Pay attention - limited upside

The 3 months correlation between Exagen and Protagonist is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Exagen i.e., Exagen and Protagonist Therapeutics go up and down completely randomly.

Pair Corralation between Exagen and Protagonist Therapeutics

Considering the 90-day investment horizon Exagen Inc is expected to generate 2.55 times more return on investment than Protagonist Therapeutics. However, Exagen is 2.55 times more volatile than Protagonist Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  294.00  in Exagen Inc on October 5, 2024 and sell it today you would earn a total of  15.00  from holding Exagen Inc or generate 5.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Exagen Inc  vs.  Protagonist Therapeutics

Exagen Inc

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Protagonist Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagonist Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Exagen and Protagonist Therapeutics

The main advantage of trading using opposite Exagen and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.

The idea behind Exagen Inc and Protagonist Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .